menu
    • menu
    [{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2011","type":"Inapplicable","leadProduct":"Ginseng Extract","moa":"Aryl hydrocarbon receptor; Interleukin-6; Prostaglandin G\/H synthase 2","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"7","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Sintesi Research Srl","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"ITALY","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"3-Glycosyl-3-odemethylthiocolchicine","moa":"Tubulin","graph1":"Neurology","graph2":"Phase II","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Indena \/ Sintesi Research Srl","highestDevelopmentStatusID":"8","companyTruncated":"Indena \/ Sintesi Research Srl"},{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Artichoke Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Pharmacology\/Toxicology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Artichoke Leaf Extract","moa":"Undisclosed","graph1":"Pharmacology\/Toxicology","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Toxicology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2016","type":"Inapplicable","leadProduct":"Gingko Biloba Extract","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase II","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"8","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Grape Seed Extract","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Undisclosed"},{"orgOrder":0,"company":"Indena","sponsor":"Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Meriva","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl"},{"orgOrder":0,"company":"Indena","sponsor":"Thorne HealthTech","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Quercetin Phytosome","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"ITALY","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Samital","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"8","companyTruncated":"Indena \/ Indena"}]

    Find Clinical Drug Pipeline Developments & Deals by Indena

    Menu

    Indena

    EVENTS

    • Webinars & Exhibitions

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Grape Seed Extract

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation

                            Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prehypertension.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 29, 2025

                            Lead Product(s) : Grape Seed Extract

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin Phytosome

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Recipient : Thorne HealthTech

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Quercetin on Metabolic Health

                            Details : Quercetin Phytosome is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            March 25, 2022

                            Lead Product(s) : Quercetin Phytosome

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Thorne HealthTech

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Meriva

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Sy...

                            Details : Meriva is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 12, 2021

                            Lead Product(s) : Meriva

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Artichoke Extract

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : Azienda di Servizi alla Persona di Pavia

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Metabolic Effects of Cynara Supplementation in Overweight and Obese Class I Subjects With Newly Detected I...

                            Details : Artichoke Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Insulin Resistance.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            November 05, 2020

                            Lead Product(s) : Artichoke Extract

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : Azienda di Servizi alla Persona di Pavia

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Gingko Biloba Extract

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase II

                            Recipient : IRCCS San Raffaele

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety of Ginkgo Biloba Leaf Extract

                            Details : Gingko Biloba Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            December 29, 2016

                            Lead Product(s) : Gingko Biloba Extract

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase II

                            Recipient : IRCCS San Raffaele

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 3-Glycosyl-3-odemethylthiocolchicine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Sintesi Research Srl

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain

                            Details : 3-Glycosyl-3-odemethylthiocolchicine is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Low Back Pain.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            October 06, 2015

                            Lead Product(s) : 3-Glycosyl-3-odemethylthiocolchicine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Sintesi Research Srl

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Artichoke Leaf Extract

                            Therapeutic Area : Pharmacology/Toxicology

                            Study Phase : Undisclosed

                            Recipient : University of Mississippi Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study

                            Details : Artichoke Leaf Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Lipid Metabolism Disorders.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            October 21, 2014

                            Lead Product(s) : Artichoke Leaf Extract

                            Therapeutic Area : Pharmacology/Toxicology

                            Highest Development Status : Undisclosed

                            Recipient : University of Mississippi Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Samital

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Recipient : Istituto Oncologico Veneto

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Pa...

                            Details : Samital (Samital) is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Squamous Cell Carcinoma of Head and Neck.

                            Product Name : Samital

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            September 13, 2013

                            Lead Product(s) : Samital

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Recipient : Istituto Oncologico Veneto

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Indena

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ginseng Extract

                            Therapeutic Area : Oncology

                            Study Phase : Phase I/ Phase II

                            Recipient : MD Anderson Cancer Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effects of Ginseng on Cancer-Related Fatigue

                            Details : Panax Ginseng is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            June 17, 2011

                            Lead Product(s) : Ginseng Extract

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I/ Phase II

                            Recipient : MD Anderson Cancer Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth